162 related articles for article (PubMed ID: 32484107)
1. Dithranol: An Insight into its Novel Delivery Cargos for Psoriasis Management.
Kadian V; Kumar S; Saini K; Kakkar V; Rao R
Curr Drug Res Rev; 2020; 12(2):82-96. PubMed ID: 32484107
[TBL] [Abstract][Full Text] [Related]
2. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
3. Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.
Lau WM; White AW; Heard CM
Pharm Res; 2010 Dec; 27(12):2734-42. PubMed ID: 20872052
[TBL] [Abstract][Full Text] [Related]
4. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
[TBL] [Abstract][Full Text] [Related]
5. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and safety of short-contact dithranol therapy in paediatric psoriasis: a prospective comparison of regular day care and day care with telemedicine.
Oostveen AM; Beulens CA; van de Kerkhof PC; de Jong EM; Seyger MM
Br J Dermatol; 2014 Feb; 170(2):454-7. PubMed ID: 24024678
[TBL] [Abstract][Full Text] [Related]
7. [Mometasone and calcipotriol optimize the initial therapeutic effect of dithranol in chronic persistent psoriasis].
Sander P; Stücker M; Hermes N; Hoffmann K; Altmeyer P
Hautarzt; 1998 Apr; 49(4):291-4. PubMed ID: 9606629
[TBL] [Abstract][Full Text] [Related]
8. Targeted 307 nm UVB-phototherapy in psoriasis. A pilot study comparing a 307 nm excimer light with topical dithranol.
Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
Skin Res Technol; 2012 May; 18(2):212-8. PubMed ID: 22092772
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
Monastirli A; Georgiou S; Pasmatzi E; Sakkis T; Badavanis G; Drainas D; Sagriotis A; Tsambaos D
Skin Pharmacol Appl Skin Physiol; 2002; 15(4):246-51. PubMed ID: 12218286
[TBL] [Abstract][Full Text] [Related]
10. Use of topical therapies for pediatric psoriasis: A systematic review.
Kravvas G; Gholam K
Pediatr Dermatol; 2018 May; 35(3):296-302. PubMed ID: 29493005
[TBL] [Abstract][Full Text] [Related]
11. [Classical topical therapy of psoriasis].
Gerdes S; Mrowietz U
Hautarzt; 2006 Aug; 57(8):666-71. PubMed ID: 16841204
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of adverse effects associated with topical treatments for psoriasis.
Bruner CR; Feldman SR; Ventrapragada M; Fleischer AB
Dermatol Online J; 2003 Feb; 9(1):2. PubMed ID: 12639460
[TBL] [Abstract][Full Text] [Related]
13. Topical therapy for psoriasis.
Lebwohl M; Abel E; Zanolli M; Koo J; Drake L
Int J Dermatol; 1995 Oct; 34(10):673-84. PubMed ID: 8537153
[No Abstract] [Full Text] [Related]
14. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
15. A novelliposomal formulation of dithranol for psoriasis: preliminary results.
Agarwal R; Saraswat A; Kaur I; Katare OP; Kumar B
J Dermatol; 2002 Aug; 29(8):529-32. PubMed ID: 12227489
[TBL] [Abstract][Full Text] [Related]
16. Treatment of psoriasis with dithranol cream compared with dithranol paste.
Young E
Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
[TBL] [Abstract][Full Text] [Related]
17. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
[TBL] [Abstract][Full Text] [Related]
18. Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol.
Poyner TF; Menday AP; Williams ZV
J Eur Acad Dermatol Venereol; 2000 May; 14(3):153-8. PubMed ID: 11032056
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol.
Agarwal R; Katare OP; Vyas SP
Int J Pharm; 2001 Oct; 228(1-2):43-52. PubMed ID: 11576767
[TBL] [Abstract][Full Text] [Related]
20. The response of uninvolved skin of patients with psoriasis to single and repeated applications of dithranol cream: an immunohistochemical assessment.
Swinkels OQ; Prins M; van Vlijmen-Willems IM; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(6):385-92. PubMed ID: 12476012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
